HC Wainwright & Co. Reiterates Buy on Emergent BioSolutions, Maintains $10 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Emergent BioSolutions (NYSE:EBS) with a Buy and maintains $10 price target.
An expert analyst says Emergent BioSolutions is a good company to own and thinks it's worth $10 per share. When experts keep saying the same positive thing, it shows they still believe in the company's future.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.